Can $BN still compound if rates stay high?

I've been trying to separate the Brookfield business from the Brookfield stock chart. Higher rates can hurt real assets, but $BN is more than a pile of buildings with one big mortgage attached.

The Q2 report shows why people like it. Distributable earnings before realizations were $1.43 billion, up from $1.25 billion a year earlier. Per-share growth was 15%. Fee-bearing capital reached $672 billion and fee-related earnings in asset management rose 20%. Wealth Solutions earned $480 million of distributable earnings in the quarter, up from $391 million. There is a real operating engine here.

But I don't think all of those earnings deserve the same multiple. Management fees from third-party capital are one thing. Insurance investment spreads are another. Cash coming from owned infrastructure, property and private equity assets has yet another set of rate and exit-price risks. Bundling them together and calling the whole thing a "compounder" skips the hard part of valuing it.

The headline $210 billion of deployable capital is a good example of why I read the footnotes. Brookfield says $114 billion of that is uncalled private fund commitments. That is money clients have committed to its funds, not $114 billion of spare cash sitting on BN's balance sheet. It can earn fees and investment returns from deploying it, but it shouldn't be counted as cash belonging to common shareholders.

On the other hand, the company repurchased about $580 million of BN shares in the first half at an average $42 per share. Its corporate debt has a weighted average term of 15 years and no 2026 maturities. That gives it some room to wait out a rough market. The catch is that assets lower down in the structure still face their own financing and valuation pressures, and insurance returns depend on the spread between investment yields and liabilities.

What I would track: fee-related earnings per share, actual sale prices against carrying values, the insurance spread, and whether distributable earnings turn into cash that can be reinvested or returned. Brookfield's distributable earnings are a management-defined measure, so I'd read them alongside IFRS results and the balance sheet.

If rates stay elevated for another few years, which part of BN do you think bends first: real estate marks, insurance, or fundraising? Or is that exactly the environment where its capital advantage matters most?

Source: Brookfield Q2 2026 results and measure definitions